title: A case of esomeprazole-induced transient diabetes and hepatitis: the role of liver inflammation in the pathogenesis of insulin resistance.
abstract: We describe a case report of a patient who developed transient type 2 diabetes after a drug-induced (esomeprazole) sub-acute hepatitis. This case evidences the pathophysiological relevance, also in humans, of liver inflammation in the pathogenesis of type 2 diabetes.
authors.affiliation: Diabetes Care Unit, Catholic University, A. Gemelli Hospital, L. Go A. Gemelli, 00168, Rome, Italy, frazac@fastwebnet.it.
authors.forename: Francesco
authors.initials: F
authors.lastname: Zaccardi
authors.forename: Dario
authors.initials: D
authors.lastname: Pitocco
authors.forename: Francesca
authors.initials: F
authors.lastname: Martini
authors.forename: Salvatore
authors.initials: S
authors.lastname: Caputo
authors.forename: Luca
authors.initials: L
authors.lastname: Miele
authors.forename: Antonio
authors.initials: A
authors.lastname: Grieco
authors.forename: Giovanni
authors.initials: G
authors.lastname: Ghirlanda
mesh_terms: D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D064098:Esomeprazole / Q000009:adverse effects*; D006801:Humans; D007249:Inflammation / Q000150:complications / Q000378:metabolism*; D007333:Insulin Resistance; D008297:Male; D008875:Middle Aged
chemical_list: D000897:Anti-Ulcer Agents; D064098:Esomeprazole